NeuroSense Therapeutics Ltd. Proceeds From Exercise Of Options
NeuroSense Therapeutics Ltd. (NRSN) reported Proceeds From Exercise Of Options of $5.00 thousand for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-04.
Discontinued › Cash Flow › Financing Activities
ifrs-full:ProceedsFromExerciseOfOptions · last filed 2024-04-04
| Period end | Proceeds From Exercise Of Options 1 month | Proceeds From Exercise Of Options 6 month | Proceeds From Exercise Of Options 12 month |
|---|---|---|---|
| 2023-12-31 | $5.00K 20-F · filed 2024-04-04 | ||
| 2023-06-30 | $5.00K 6-K · filed 2023-08-16 | ||
| 2022-12-31 | $3.87M 20-F · filed 2024-04-04 | ||
| 2022-06-30 | $3.87M 6-K · filed 2023-08-16 | ||
| 2021-12-31 | $1.24M 20-F · filed 2024-04-04 | ||
| 2021-10-31 | $76.00K 20-F · filed 2022-04-14 |